Suchergebnisse - "Bell, Benjamin N."

PubPharm (6)

1

HIV-1 prehairpin intermediate inhibitors show efficacy independent of neutralization tier

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2023

von Bell, B. | Bruun, T. | Friedland, N. | +1

2

Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors

enthalten in: Nature chemical biology | 2022

von Weidenbacher, P. | Waltari, E. | de Los Rios Kobara, I. | +6

3

A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity

enthalten in: Journal of virology | 2021

von Rubio, A. | Filsinger Interrante, M. | Bell, B. | +5

4

Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library

enthalten in: Protein science : a publication of the Protein Society | 2021

von Bell, B. | Powell, A. | Rodriguez, C. | +2

5

The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2021

von Montefiori, D. | Filsinger Interrante, M. | Bell, B. | +5

CommentIn: Proc Natl Acad Sci U S A. 2021 Feb 16;118(7):. - PMID 33504595

6

Crystal structure of AdoMet radical enzyme 7-carboxy-7-deazaguanine synthase from Escherichia coli suggests how modifications near [4Fe-4S] cluster engender flavodoxin specificity

enthalten in: Protein science : a publication of the Protein Society | 2019

von Grell, T. | Bell, B. | Nguyen, C. | +4

1
[1]